BridgeBio Pharma, Inc.BBIONASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank100
3Y CAGR+8.8%
5Y CAGR+23.1%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+8.8%/yr
vs +137.1%/yr prior
5Y CAGR
+23.1%/yr
Recent deceleration
Acceleration
-128.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
8 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $103.52M | +4.3% |
| 2024 | $99.29M | +22.1% |
| 2023 | $81.29M | +1.1% |
| 2022 | $80.44M | +72.0% |
| 2021 | $46.78M | +27.6% |
| 2020 | $36.66M | +318.2% |
| 2019 | $8.77M | +244.1% |
| 2018 | $2.55M | +19492.3% |
| 2017 | $13000.00 | - |